Corcept Therapeutics (FRA:HTD) Other Financing : €0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Corcept Therapeutics Other Financing?

Corcept Therapeutics's Other Financing for the three months ended in Dec. 2024 was €0.0 Mil.

Corcept Therapeutics's Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 was €0.0 Mil.

Corcept Therapeutics Other Financing Historical Data

The historical data trend for Corcept Therapeutics's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corcept Therapeutics Other Financing Chart

Corcept Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Financing

Get a 7-Day Free Trial

18.22

-5.85

-3.02

Corcept Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Financing	Get a 7-Day Free Trial															-	-	-	-	-

Corcept Therapeutics Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Corcept Therapeutics Other Financing Related Terms

Thank you for viewing the detailed overview of Corcept Therapeutics's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Corcept Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corcept Therapeutics Inc (FRA:HTD) » Definitions » Other Financing

Comparable Companies

Traded in Other Exchanges

CORT:USA 0I3Q:UK HTD:Germany

Address

101 Redwood Shores Parkway, Redwood City, CA, USA, 94065

Website

https://www.corcept.com

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.